TOBI 300 mg/5 ml Nebuliser Solution
Last Updated on eMC 22-Apr-2016 View document | Novartis Pharmaceuticals UK Ltd Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 22-Apr-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 15-Aug-2013 and displayed until 22-Apr-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children/adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - dose and frequency
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store
- Change to section 6 - date of revision
Updated on 12-Mar-2013 and displayed until 15-Aug-2013
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26-Sep-2011 and displayed until 12-Mar-2013
Reasons for adding or updating:
- Change to side-effects
- Change to MA holder contact details
Updated on 28-May-2010 and displayed until 26-Sep-2011
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 23-Apr-2007 and displayed until 28-May-2010
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 18-Apr-2007 and displayed until 23-Apr-2007
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
+44 (0)1276 692 255
+44 (0)1276 698 370
+44 (0)845 741 9442
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue